Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Eurocell (ECEL) by Steve Moore in ShareProphets
- Avoid DFS Furniture (DFS) by Steve Moore in ShareProphets
- Avoid Focusrite (TUNE) by Steve Moore in ShareProphets
- Overweight Sage Group (SGE) by JP Morgan
- Sector Perform Sabre Insurance Group (SBRE) by RBC Capital
- Overweight Centrica (CNA) by JP Morgan
- Hold BP (BP.) by HSBC
- Buy Softcat (SCT) by Berenberg
- Buy Eurocell (ECEL) by Berenberg
- Buy Essentra (ESNT) by Berenberg
- Buy Rockhopper Exploration (RKH) by Canaccord Genuity
- Speculative Buy Atlantic Lithium Limited NPV (DI) (ALL) by Canaccord Genuity
- Buy YouGov (YOU) by Canaccord Genuity
- Buy Softcat (SCT) by Shore Capital
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Buy PCI-PAL (PCIP) by Canaccord Genuity
- Buy Trainline (TRN) by Canaccord Genuity
- Hold Tinybuild Inc. (DI) (TBLD) by Shore Capital
- Buy Wickes Group (WIX) by Canaccord Genuity
- Hold Clarkson (CKN) by Canaccord Genuity
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 9.00p | Latest Ask : 10.50p |
| High Today : 11.00p | Low Today : 9.00p |
| This Years High : 12.10p | This Years Low : 5.25p |
| Volume : 7,806 | MKT Cap : £500.43M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-01-16 10:15:00 16/01/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-28 09:50:00 28/11/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-09-25 09:55:00 25/09/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-07-11 10:15:00 11/07/2019 | – |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 9.00p | Latest Ask : 10.50p |
| High Today : 11.00p | Low Today : 9.00p |
| This Years High : 12.10p | This Years Low : 5.25p |
| Volume : 7,806 | MKT Cap : £500.43M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |
| Corporate | FinnCap | Premium Only | 2020-01-16 10:15:00 16/01/2020 | – |
| Corporate | FinnCap | Premium Only | 2019-11-28 09:50:00 28/11/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-09-25 09:55:00 25/09/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-07-11 10:15:00 11/07/2019 | – |